Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X Y
Z
A
Abbreviations
Abdominal Wound Infection
aciclovir
breastfeeding
encephalitis
herpes simplex
OAT (transporter)
OATP (transporter)
renal impairment
shingles
Adverse Drug Reactions
Adverse Drug Reaction (ADR) Reporting Guidelines
Assessing Adverse Drug Reactions
Allergic Disorders
penicillin allergy
allopurinol
renal impairment
xanthine oxidase
amantadine
anticholinergic
renal impairment
Aminoglycosides
dosing guidelines
Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
renal impairment
therapeutic drug monitoring
amiodarone
breastfeeding
CYP1A2
CYP2C8/9
CYP3A
drug-drug interactions
P-glycoprotein
QT prolongation
therapeutic drug monitoring
amisulpride
anticholinergic
amitriptyline
anticholinergic
CYP2D6
serotonergic
amlodipine
CYP3A
amoxicillin
acute peritonitis
bacterial endocarditis prophylaxis
breastfeeding
cellulitis
cholecystitis/cholangitis
COPD exacerbations
Empiric
Pathogens Known
cystitis
H. pylori eradication
IV to oral
meningitis
pneumonia
Empiric
Pathogens Known
post-op urosepsis
pyelonephritis
sinusitis
amoxicillin/clavulanate
acute epiglottitis
acute peritonitis
bites
cellulitis
cholecystitis/cholangitis
COPD exacerbations
Empiric
Pathogens Known
cystitis
deep neck space infections
IV to oral
mastitis
pneumonia
Empiric
Hospital-acquired Pneumonia
Pathogens Known
post-op abdominal wound infection
prostatitis
sinusitis
Acute Rhinosinusitis
Chronic Rhinosinusitis
surgical prophylaxis
Angiotensin-2 Receptor Antagonists
CYP2C8/9
Anti-Arrhythmics
CYP2D6
Anticholinergic toxicity
Anticoagulants
drug-drug interactions
Antidepressants
anticholinergic
breastfeeding
CYP2D6
drug-drug interactions
elderly
liver impairment
pregnancy
QT prolongation
serotonergic
Antiepileptics
drug-drug interactions
Antifungals
candidal vulvovaginitis
CYP3A
drug-drug interactions
therapeutic drug monitoring
Antihistamines
anticholinergic
breastfeeding
Antihypertensives
drug and food interactions
pregnancy
Antimicrobial advice and allergy
General Antimicrobial Advice
Penicillin Allergy
Antimicrobial Guidelines
Antimicrobial IV to oral switch
Antipsychotics
CYP2D6
liver impairment
Antivirals
influenza
aripiprazole
anticholinergic
CYP2D6
CYP3A
atenolol
renal impairment
atomoxetine
CYP2D6
atorvastatin
CYP3A
azathioprine
dosing guideline
drug-drug interactions
pharmacogenetics
prodrugs and dosing
therapeutic drug monitoring
azithromycin
breastfeeding
chlamydia
conjunctivitis
CYP3A
diarrhoea
gonorrhoea
pelvic inflammatory disease
pertussis
pneumonia
Empiric
Pathogens Known
QT prolongation
urethritis (non-gonococcal)
B
baclofen
anticholinergic
renal impairment
Bacteraemia (MRSA guideline)
Bacterial Endocarditis
prophylaxis
treatment
Bacterial Vaginosis
Benzodiazepines
breastfeeding
CYP3A
elderly
glucuronidation
benztropine
anticholinergic
benzylpenicillin (Penicillin G)
acute peritonitis
bacterial endocarditis
cellulitis
group A strep (with MRSA)
group B streptococcus prophylaxis
IV to oral
meningitis
necrotising soft tissue infection
osteomyelitis/septic arthritis
Beta-2-Adrenoceptor Stimulants
conjugation
Beta-Adrenoceptor Blocking Drugs
breastfeeding
CYP2D6
CYP3A
bezafibrate
CYP3A
Bile sequestrants (PML)
drug and food interactions
Bites
Bone and Joint Infections
Breastfeeding – prescribing in
bupropion
CYP2D6
buspirone
CYP3A
serotonergic
C
calcium
drug and food interactions
Calcium Channel Blockers
breastfeeding
CYP3A
candesartan
CYP2C8/9
renal impairment
Candidal Vulvovaginitis
carbamazepine
anticholinergic
breastfeeding
conjugation
CYP2C19
CYP3A
drug and food interactions
pharmacogenetics
pregnancy
serotonergic
therapeutic drug monitoring
Carbapenems
penicillin allergy
renal impairment
carbimazole
pregnancy
Cardiovascular System
Antimicrobial guidelines
carvedilol
CYP2D6
P-glycoprotein
cefalexin
breastfeeding
cellulitis
cystitis
deep neck space infections
mastitis
osteomyelitis/septic arthritis
pyelonephritis
cefazolin
bacterial endocarditis
cellulitis
group B streptococcus prophylaxis
MRSA guideline
necrotising soft tissue infection
osteomyelitis/septic arthritis
pneumonia
post-op septicaemia
probenecid
pyomyositis
surgical prophylaxis
cefotaxime
acute peritonitis
ceftriaxone
acute epiglottitis
breastfeeding
deep neck space infections
diarrhoea - infection associated
gonorrhoea
meningitis
necrotising soft tissue infection
pelvic inflammatory disease
penicillin allergy
pneumonia
pyelonephritis
renal impairment
septicaemia
cefuroxime
acute epiglottitis
acute peritonitis
bites
cellulitis
cholecystitis/cholangitis
COPD exacerbations
Empiric
Pathogens Known
penicillin allergy
pneumonia
Empiric
Hospital-acquired Pneumonia
Pathogens Known
post-op abdominal wound infection
post-op septicaemia
prostatitis
septicaemia
surgical prophylaxis
celiprolol
P-glycoprotein
Cellulitis
complicated/ulcers
post-op
simple
Central Nervous System
Antimicrobial Guidelines
Cephalosporins
breastfeeding
OAT (transporter)
penicillin allergy
renal impairment
cervicitis
Chlamydial Cervicitis / Urethritis / Proctitis
Gonorrhoea
cetirizine
anticholinergic
OCT (transporter)
renal impairment
Charting
chloramphenicol
conjugation
conjunctivitis
CYP2C19
chlorhexidine
MRSA guideline
chlorpromazine
anticholinergic
breastfeeding
CYP2D6
Cholecystitis/Cholangitis
cholestyramine
drug and food interactions
ciclosporin
CYP3A
OAT (transporter)
OATP (transporter)
P-glycoprotein
therapeutic drug monitoring
cigarette smoking
CYP1A2
cilazapril
renal impairment
ciprofloxacin
breastfeeding
CYP1A2
CYP3A
diarrhoea - infection associated
epiglottitis
gonorrhoea
IV to oral
meningitis
OAT (transporter)
OATP (transporter)
prostatitis
pyelonephritis
sinusitis
citalopram
breastfeeding
QT prolongation
serotonergic
clarithromycin
breastfeeding
CYP2C19
CYP3A
drug-drug interactions
H. pylori eradication
IV to oral
pneumonia
QT prolongation
clindamycin
bacterial endocarditis prophylaxis
bites
cellulitis
Cellulitis - Simple and Erysipelas
Infected Ulcers (e.g. diabetic, vascular, pressure)
deep neck space infections
epiglottitis
mastitis
MRSA
necrotising soft tissue infection
pelvic inflammatory disease
pneumonia
post-op abdominal wound infection
surgical prophylaxis
clomipramine
anticholinergic
CYP1A2
CYP2D6
serotonergic
clonazepam
CYP3A
clopidogrel
CYP2C19
pharmacogenetics
prodrugs and dosing
clotrimazole
candidal vulvovaginitis
clozapine
anticholinergic
CYP1A2
therapeutic drug monitoring
codeine
anticholinergic
CYP2D6
drug-drug interactions
pharmacogenetics
prodrugs and dosing
colchicine
P-glycoprotein
Conjugation
Conjunctivitis
COPD exacerbations
Empiric
Pathogens Known
Corticosteroids
CYP3A
meningitis
cyclophosphamide
CYP2C19
Cystitis
Cytochrome P450 1A2 (CYP1A2)
Cytochrome P450 2C19 (CYP2C19)
Cytochrome P450 2C8/9 (CYP2C8/9)
Cytochrome P450 2D6 (CYP2D6)
Cytochrome P450 3A (CYP3A)
D
dabigatran etexilate
drug-drug interactions
PgP
renal impairment
dalteparin
renal impairment
Deep neck space infections
dexamethasone
CYP3A
meningitis
Diarrhoea
antimicrobial associated
infection associated
diazepam
CYP2C19
CYP3A
diclofenac
breastfeeding
CYP2C8/9
digoxin
anticholinergic
breastfeeding
P-glycoprotein
renal impairment
therapeutic drug monitoring
dihydrocodeine
CYP2D6
diltiazem
breastfeeding
CYP3A
P-glycoprotein
Discharge Prescribing
Diuretics
drug and food interactions
domperidone
breastfeeding
CYP3A
QT prolongation
doxazosin
CYP3A
doxepin
anticholinergic
CYP2D6
serotonergic
doxycycline
bites
breastfeeding
chlamydia
COPD exacerbations
Empiric
Pathogens Known
mastitis
pelvic inflammatory disease
pneumonia
Empiric
Pathogens Known
sinusitis
Acute Rhinosinusitis
Chronic Rhinosinusitis
Drug - food interaction
Drug Concentration Monitoring
Drug Information Service (DIS)
Drug Profile Tables
Drug Profiles
Drug-drug interaction
E
Ear, Nose & Oropharynx
Antimicrobial guidelines
eformoterol
glucuronidation
Elderly - prescribing in
enalapril
renal impairment
Encephalitis
enoxaparin
breastfeeding
renal impairment
entacapone
anticholinergic
glucuronidation
Epidural abscess
Epiglottitis
erythromycin
breastfeeding
CYP3A
drug-drug interactions
pelvic inflammatory disease
P-glycoprotein
QT prolongation
escitalopram
breastfeeding
QT prolongation
serotonergic
ethambutol
renal impairment
Eye
Antimicrobial guidelines
ezetimibe
glucuronidation
F
felodipine
CYP3A
fentanyl
CYP3A
finasteride
CYP3A
flecainide
CYP2D6
QT prolongation
therapeutic drug monitoring
flucloxacillin
bacteraemia (MRSA guideline)
bacterial endocarditis
cellulitis
IV to oral
mastitis
necrotising soft tissue infection
osteomyelitis/septic arthritis
pneumonia
post-op abdominal wound infection
post-op septicaemia
probenecid
pyomyositis
sinusitis
Acute Rhinosinusitis
Chronic Rhinosinusitis
fluconazole
candidal vulvovaginitis
CYP2C19
CYP2C8/9
CYP3A
renal impairment
fludrocortisone
CYP3A
fluoxetine
CYP2C19
CYP2D6
serotonergic
flutamide
CYP1A2
CYP3A
Food and Drug Interactions
fosfomycin
cystitis
frusemide
OAT (transporter)
furosemide
OAT (transporter)
G
gabapentin
renal impairment
Gastrointestinal System
Antimicrobial guidelines
gentamicin
acute peritonitis
bacterial endocarditis
cellulitis
cholecystitis/cholangitis
dosing guidelines
Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
IV to oral
necrotising soft tissue infection
pelvic inflammatory disease
pneumonia
Empiric
Hospital-acquired Pneumonia
post-op abdominal wound infection
post-op limb wound infection
post-op pneumonia
post-op septicaemia
post-op urosepsis
prostatitis
pyelonephritis
renal impairment
septicaemia
surgical prophylaxis
therapeutic drug monitoring
Gentamicin/Tobramycin Dosing
Gentamicin/Tobramycin Dosing Guidelines (Adults)
Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
glibenclamide
CYP2C8/9
OATP (transporter)
gliclazide
CYP2C8/9
glipizide
CYP2C8/9
Glucuronidation
Gonorrhoea
Group B streptococcus prophylaxis
H
H. pylori eradication
haloperidol
anticholinergic
CYP2D6
CYP3A
heparin
breastfeeding
Herpes Simplex
encephalitis
orofacial/genital
HIV
CYP3A
P-glycoprotein
hyoscine (PML)
anticholinergic
I
ibuprofen
CYP2C8/9
imipenem/cilastatin
renal impairment
imipramine
anticholinergic
CYP2C19
CYP2D6
serotonergic
Immunosuppressants
breastfeeding
CYP3A
P-glycoprotein
Influenza
Insulins
breastfeeding
metabolism
Intravenous to oral antimicrobials
Introduction
Aspects of Individualising Drug Therapy
Pink Book
isoniazid
conjugation
CYP2C19
CYP2C8/9
isotretinoin
breastfeeding
pregnancy
itraconazole
CYP3A
P-glycoprotein
therapeutic drug monitoring
K
ketoconazole
CYP1A2
CYP2C19
CYP2C8/9
CYP3A
P-glycoprotein
L
labetalol
breastfeeding
lamivudine
renal impairment
lamotrigine
glucuronidation
pregnancy
therapeutic drug monitoring
lansoprazole
CYP2C19
Laxatives (PML)
drug and food interactions
levetiracetam
renal impairment
levodopa/benserazide
anticholinergic
levodopa/carbidopa
anticholinergic
lignocaine
CYP2D6
CYP3A
liver impairment
Limb wound infection - post-op
lithium
breastfeeding
Drug-drug interaction
pregnancy
QT prolongation
renal impairment
serotonergic
therapeutic drug monitoring
Liver impairment- prescribing in
loperamide
anticholinergic
CYP3A
P-glycoprotein
loratadine
anticholinergic
breastfeeding
CYP3A
lorazepam
glucuronidation
losartan
CYP2C8/9
M
Macrolides
CYP3A
drug-drug interactions
QT prolongation
Mastitis / Breast Abscess
Meningitis
6-mercaptopurine
dosing guideline
pharmacogenetics
prodrugs and dosing
Therapeutic Drug Monitoring
meropenem
pneumonia
post-op pneumonia
post-op septicaemia
renal impairment
septicaemia
mesalazine
breastfeeding
Metabolism - drugs
metformin
breastfeeding
OCT (transporter)
renal impairment
methadone
CYP3A
QT prolongation
methotrexate
pregnancy
renal impairment
methyldopa
breastfeeding
methylprednisolone
CYP3A
metoclopramide
anticholinergic
CYP2D6
metoprolol
breastfeeding
CYP2D6
drug and food interactions
metronidazole
acute peritonitis
bacterial vaginosis
bites
cellulitis
cholecystitis/cholangitis
deep neck space infections
diarrhoea - antimicrobial associated
H. pylori eradication
IV to oral
parasitic GI infection
pelvic inflammatory disease
post-op abdominal wound
post-op septicaemia
septicaemia
surgical prophylaxis
trichomoniasis
midazolam
breastfeeding
CYP3A
mirtazapine (PML)
anticholinergic
serotonergic
moclobemide
breastfeeding
CYP2C19
CYP2D6
drug and food interactions
serotonergic
Monoamine-Oxidase Inhibitors (PML)
serotonergic
morphine
breastfeeding
glucuronidation
P-glycoprotein
renal dysfunction
MRSA
bacteraemia
co-infection with group A strep
decolonization
soft tissue infection
mupirocin
MRSA guideline
mycophenolate
glucuronidation
therapeutic drug monitoring
N
nadolol
renal impairment
naloxone
glucuronidation
naproxen
CYP2C8/9
Necrotising soft tissue infection
nifedipine
CYP3A
P-glycoprotein
nitazoxanide
parasitic GI infection
Nitrates
liver impairment
nitrofurantoin
breastfeeding
cystitis
Non Steroidal Anti-inflammatory Drugs (NSAIDs)
breastfeeding
drug-drug interactions
elderly
liver impairment
pregnancy
norfloxacin
breastfeeding
cystitis
nortriptyline
anticholinergic
breastfeeding
CYP2D6
serotonergic
nystatin
candidal vulvovaginitis
O
OAT (transporter)
OATP (transporter)
Obese - prescribing in
Obstetrics, Gynaecology (Antimicrobial Guidelines)
OCT (transporter)
oestradiol
CYP3A
olanzapine
anticholinergic
CYP1A2
omeprazole
CYP2C19
H. pylori eradication
ondansetron
CYP2D6
Opioids
drug and food interactions
glucuronidation
liver impairment
pregnancy
ornidazole
bacterial vaginosis
parasitic GI infection
trichomoniasis
oseltamivir
influenza
renal impairment
Osteomyelitis/septic arthritis
oxazepam
glucuronidation
oxybutynin
anticholinergic
oxycodone
breastfeeding
P
pantoprazole
CYP2C19
paracetamol
breastfeeding
glucuronidation
liver impairment
Parasitic GI infection
paroxetine
anticholinergic
breastfeeding
CYP2D6
serotonergic
Pelvic Inflammatory Disease
Penicillins
allergy
OAT (transporter)
renal impairment
perhexiline
CYP2D6
pharmacogenetics
therapeutic drug monitoring
Peritonitis - acute
Pertussis
P-glycoprotein
Pharmacogenetics
Pharmacology Guidelines
Pharyngitis
phenoxymethylpenicillin (Penicillin V)
cellulitis
group A strep (with MRSA)
IV to oral
pharyngitis
phenytoin
breastfeeding
CYP1A2
CYP2C19
CYP2C8/9
CYP3A
glucuronidation
pregnancy
therapeutic drug monitoring
piperacillin/tazobactam (Tazocin™)
pneumonia
post-op pneumonia
post-op septicaemia
septicaemia
pizotifen
glucuronidation
Pneumonia
community-acquired
hospital-acquired
post-op
Polypharmacy toxicities - common
pramipexol
anticholinergic
renal dysfunction
transporter
prednisolone
CYP3A
prednisone
breastfeeding
Pregnancy – prescribing in
Prescribing Instructions
probenecid
cefazolin
flucloxacillin
OAT (transporter)
OATP (transporter)
prochlorperazine
anticholinergic
procyclidine
anticholinergic
Prodrugs and dosing
Progestogens
breastfeeding
CYP3A
P-glycoprotein
promethazine
anticholinergic
CYP2D6
propranolol
breastfeeding
CYP2D6
CYP3A
Prostatitis
Pyelonephritis
Pyomyositis
Q
QT prolongation
quetiapine
anticholinergic
CYP3A
quinapril
breastfeeding
renal impairment
Quinolones
breastfeeding
CYP1A2
drug and food interactions
R
ranitidine
anticholinergic
breastfeeding
flavin monooxygenase
renal impairment
Renal impairment - prescribing in
Respiratory System
Antimicrobial guidelines
rifampicin
CYP1A2
CYP2C19
CYP2C8/9
CYP3A
Drug-drug interaction
glucuronidation
OAT (transporter)
OATP (transporter)
P-glycoprotein
risperidone
anticholinergic
CYP2D6
CYP3A
ropinirole
anticholinergic
CYP1A2
Routes of Administration
roxithromycin
breastfeeding
CYP3A
IV to oral
P-glycoprotein
pharyngitis
QT prolongation
sinusitis
Acute Rhinosinusitis
Chronic Rhinosinusitis
S
salbutamol
conjugation
pregnancy
salmeterol
conjugation
selegiline
anticholinergic
CYP2C19
senna
drug and food interactions
Septic Arthritis
Septicaemia
Serotonin toxicity
sertraline
CYP2D6
serotonergic
Sexually transmitted diseases
Shingles
simvastatin
CYP3A
drug and food interactions
P-glycoprotein
Sinusitis
Acute Rhinosinusitis
Chronic Rhinosinusitis
Skin
Antimicrobial guidelines
solifenacin
anticholinergic
sotalol
QT prolongation
renal impairment
SSRIs
serotonergic
Statins
CYP3A
liver impairment
Steroids
CYP3A
meningitis
Stimulant laxatives
drug and food interactions
sumatriptan
serotonergic
Surgical Post-Operative Antimicrobials
Surgical Prophylaxis Antimicrobials
Syphilis
T
tacrolimus
CYP3A
P-glycoprotein
therapeutic drug monitoring
tamoxifen
CYP2D6
P-glycoprotein
pharmacogenetics
prodrugs and dosing
teicoplanin
temazepam
glucuronidation
terbinafine
CYP2D6
testosterone
CYP3A
Tetracyclines
breastfeeding
drug and food interactions
pregnancy
theophylline
CYP1A2
drug-drug interactions
therapeutic drug monitoring
Therapeutic Drug Monitoring
ticagrelor
CYP3A
timolol
CYP2D6
tobramycin
dosing guidelines
Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
renal impairment
therapeutic drug monitoring
tolterodine
CYP2D6
topiramate
renal impairment
tramadol
CYP2D6
serotonergic
tranexamic acid
renal impairment
Transport - drugs
Trichomoniasis
Tricyclic Antidepressants
breastfeeding
elderly
QT prolongation
serotonergic
trimethoprim
breastfeeding
cystitis
pyelonephritis
renal impairment
trimethoprim/sulfamethoxazole (co-trimoxazole)
bites
breastfeeding
conjugation
CYP2C8/9
diarrhoea - infection associated
meningitis
MRSA soft tissue infection
parasitic GI infection
pertussis
prostatitis
renal impairment
U
Urethritis
Chlamydial Cervicitis / Urethritis / Proctitis
Gonorrhoea
Non-Gonococcal Urethritis
Urinary Tract Infections
Urosepsis - post-op
V
valproate
breastfeeding
glucuronidation
pregnancy
serotonergic
therapeutic drug monitoring
vancomycin
bacterial endocarditis
bacterial endocarditis prophylaxis
diarrhoea - antimicrobial associated
dosing guidelines
Continuous Infusions
Vancomycin Dosing Guidelines (Adults)
Group B streptococcus prophylaxis
meningitis
MRSA
osteomyelitis/septic arthritis
pneumonia
Empiric
Pathogens Known
renal impairment
surgical prophylaxis
therapeutic drug monitoring
varenicline
OCT (transporter)
Varicella zoster
venlafaxine
anticholinergic
breastfeeding
CYP2D6
serotonergic
verapamil
CYP3A
P-glycoprotein
Vitamin A
pregnancy
Vitamin D
drug and food interactions
Vitamin K
drug and food interactions
liver impairment
voriconazole
CYP2C8/9
CYP3A
therapeutic drug monitoring
W
warfarin
anticholinergic
breastfeeding
CYP2C8/9
drug and food interactions
drug-drug interactions
pharmacogenetics
pregnancy
Z
ziprasidone
CYP3A